ArticleZeitschrift fur Rheumatologie2024

Comparison of the efficacy and safety of tocilizumab, sarilumab, and olokizumab in patients with active rheumatoid arthritis: a network meta-analysis of randomized controlled trials.

Young Ho Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.